Effects of an Immersive Virtual Reality Program

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-25
SponsorUniversidad Autónoma de Chile

About this trial

A tool that could be useful to eliminate the barriers of not practicing physical activity can be immersive virtual reality, which is characterized by being a technique where a person, through the use of a screen mounted on the head, receives images, sounds and tactile sensations of a simulated world.

In the area of physical exercise, evidence places immersive virtual reality as a tool that encourages healthy behaviors and the practice of physical activity, increasing adherence to exercise in the long term. In addition to the fact that performing physical activity by this means generates a high level of enjoyment in the participants, so if the use of this technology generates enjoyment in those who use it and contributes to complying with the recommendations of physical activity, it is logical to think that a physical exercise program executed through immersive virtual reality could contribute to improving parameters related to people's health. Therefore, the objective of this randomized controlled trial is to evaluate the effect of a physical exercise program carried out through immersive virtual reality on health-related variables.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Be a university student

Present medical consent authorizing the performance of physical activity

Signing of informed consent

Disqualifiers

Have a physical or mental impairment that prevents you from engaging in physical activity

Have a vision impairment that does not allow you to use the immersive virtual reality

Belong to a special interest group (professional athletes or pregnant women)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Physical activity

    Other intervention

    Implementation of a physical activity program, executed through immersive virtual reality

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: ExperimentalExperimental treatment 1 intervention
Group B: Experimental 2Experimental treatment 1 intervention
Group C: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Physical fitness

Cardiorespiratory fitness will be measured through the 20-meter shuttle run test, and maximum oxygen consumption will be estimated. Lower body muscle strength will be measured through the long jump test. Upper body muscle strength will be measured through manual grip strength (Takei 5401). Speed/agility will be assessed through the 4x10 test.

Time frame
From registration to the end of the physical activity intervention, it will be a period of 16 weeks.
2

Body Composition

Weight will be evaluated through a scale (Seca 222), with the participant barefoot and with the least possible clothing. Size will be obtained with a height gauge (Seca 222), with the participant barefoot, in an upright position, at the end of a normal inspiration. Both measures will be taken in duplicate, using the mean for statistical analyses. Body mass index will be determined by dividing weight by height squared. Waist circumference will be determined at the midpoint between the last rib and the iliac crest. The average of two measurements will be used. The percentage of adipose and muscle tissue will be calculated by means of tetrapolar electrical bioimpedance (Tanita MC 780U). It will be complemented by the measurement of body perimeters, bone diameters and skin folds, according to the protocol described by the International Society for the Advancement of Kineanthropometry.

Time frame
From registration to the end of the physical activity intervention, it will be a period of 16 weeks.

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: